Clinical profile and outcome of cardiac manifestations in patients presenting with multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection
- PMID: 37767171
- PMCID: PMC10522157
- DOI: 10.4103/apc.apc_18_23
Clinical profile and outcome of cardiac manifestations in patients presenting with multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection
Abstract
Multisystem inflammatory syndrome in children (MIS-C) can cause significant morbidity and mortality in children. This study was conducted to assess the pattern and outcome of cardiac abnormalities in MIS-C. This retrospective study was conducted in children with MIS-C between 1 month and 18 years. We enrolled 53 children with a mean age of 7.78 ± 4.62 years. Overall, 35.8% of children with MIS-C had cardiac manifestations in the form of coronary artery abnormalities (CAAs) or left ventricular (LV) dysfunction. Younger age (P 0.009) and high C-reactive protein at admission (P = 0.001) were significant predictors of cardiac involvement. CAAs were seen in 11.3% of children. On follow-up, 67% and 83% of children showed regression of CAA at 1 and 6 months, respectively. 24.5% of patients had presented with LV dysfunction. LV ejection fraction improved significantly at 1 month (P = 0.002) and 6 months (P = 0.001). Cardiac outcomes in MIS-C were favorable with timely identification and treatment.
Keywords: Cardiac outcome; coronary artery abnormalities; left ventricular dysfunction; multisystem inflammatory syndrome in children.
Copyright: © 2023 Annals of Pediatric Cardiology.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Clinical profile and outcomes of multisystem inflammatory syndrome in children (MIS-C): Hospital-based prospective observational study from a tertiary care hospital in South India.J Paediatr Child Health. 2022 Nov;58(11):1964-1971. doi: 10.1111/jpc.16129. Epub 2022 Jul 23. J Paediatr Child Health. 2022. PMID: 35869845
-
Cardiac Assessment in Children with MIS-C: Late Magnetic Resonance Imaging Features.Pediatr Cardiol. 2023 Jan;44(1):44-53. doi: 10.1007/s00246-022-02977-y. Epub 2022 Aug 2. Pediatr Cardiol. 2023. PMID: 35916926 Free PMC article.
-
Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland.Biomedicines. 2023 Apr 23;11(5):1251. doi: 10.3390/biomedicines11051251. Biomedicines. 2023. PMID: 37238922 Free PMC article.
-
Multisystem Inflammatory Syndrome in Children (MIS-C).Curr Allergy Asthma Rep. 2022 May;22(5):53-60. doi: 10.1007/s11882-022-01031-4. Epub 2022 Mar 22. Curr Allergy Asthma Rep. 2022. PMID: 35314921 Free PMC article. Review.
-
Longitudinal Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis.Pediatr Cardiol. 2023 Apr;44(4):892-907. doi: 10.1007/s00246-022-03052-2. Epub 2022 Nov 22. Pediatr Cardiol. 2023. PMID: 36416893 Free PMC article.
Cited by
-
Trends of Cardiac Complaints in Pediatric and Young Adult Populations During the COVID-19 Pandemic.J Cardiovasc Dev Dis. 2025 Apr 7;12(4):138. doi: 10.3390/jcdd12040138. J Cardiovasc Dev Dis. 2025. PMID: 40278197 Free PMC article.
-
COVID-19 and heart disease in children: What have we learned?Ann Pediatr Cardiol. 2023 Mar-Apr;16(2):81-86. doi: 10.4103/apc.apc_104_23. Epub 2023 Aug 16. Ann Pediatr Cardiol. 2023. PMID: 37767179 Free PMC article. No abstract available.
References
-
- Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19) May 2020. [[Last accessed on 18 Dec 2022]]. Available online: https://emergency.cdc.gov/han/2020/han00432.asp .
-
- Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific brief: World Health Organization 15 May 2020. [[Last accessed on 18 Dec 2022]]. Available from: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrom... .
-
- McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–99. - PubMed
-
- Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: Version 1. Arthritis Rheumatol. 2020;72:1791–805. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous